Abraham Goldin Papers

Collection

Identifier: MS C 594

Abstract

Correspondence, and notes from meetings and conferences concerning the experimental design of, and protocols for, drugs used in chemotherapy, along with reprints of scientific articles authored by Dr. Goldin.

Dates

Creation: 1937-1988

Extent

6.25 Linear Feet (5 boxes)

Creator

Goldin, Abraham (Person)

Physical Location

Materials stored onsite. History of Medicine Division. National Library of Medicine

Language of Materials

Collection materials primarily in English

Access Restrictions

No restrictions on access.

Copyright and Re-use Information

Donor's copyrights were transferred to the public domain. Archival collections often contain mixed copyrights; while NLM is the owner of the physical items, permission to examine collection materials is not an authorization to publish. These materials are made available for use in research, teaching, and private study. It is the user's responsibility to research and understand any applicable copyright and re-publication rights not allowed by fair use. NLM does not grant permissions to publish.

Privacy Information

Archives and manuscript collections may contain materials with sensitive or confidential information that is protected under federal or state right to privacy laws and regulations. Researchers are advised that the disclosure of certain information pertaining to identifiable living individuals represented in any collection without the consent of those individuals may have legal ramifications for which the National Library of Medicine assumes no responsibility.

Biographical Note

Born on December 10, 1911 in New York City, Abraham Goldin studied biology at Brooklyn College before earning a Ph.D. in zoology at Columbia University in 1942. While completing his studies at Columbia, he taught laboratory biology at Queens College. After World War II military service, Dr. Goldin served as chief of the Biology Section at the Army Chemical Center at Edgewood, Maryland from 1946 to 1949 before concentrating his studies to the Department of Preventive Medicine at Johns Hopkins University.

In 1952 he joined the Pharmacology Section of the National Cancer Institute's Laboratory of Chemical Pharmacology, as head of the Baltimore group of biologists. Spending the rest of his career at NCI, Dr. Goldin retired as Assistant Director for International Treatment Research in the Division of Cancer Treatment in 1983.

Dr. Goldin's work at NCI concentrated on the study of tumor biology and cancer chemotherapy. Through experimentation with treatment of animal tumors, he is considered a pioneer in experimental cancer therapeutics. He is credited with identifying hybrid resistance, and the syndrome of meningeal leukemia, and was a leader in the design, development, and combined use of drugs for chemotherapy. In these efforts, he was also an early proponent of international cooperation in the research and design of chemotherapy treatments.

Concurrently, Dr. Goldin also held an adjunct professorship at Brandeis University (1957-1968) and a research consultant position at George Washington University Medical School's Pharmacology Department (1960-1983) as well as editorships with the journals Advances in Pharmacology and Chemotherapy, and Cancer Research.

After 1983, Goldin continued work at NCI as scientist emeritus until his death in 1988.

Collection Summary

Collection consists primarily of Abraham Goldin's correspondence with pharmaceutical companies and scientific publications (1975-1988) and data from meetings in the United States and abroad regarding the advancement of chemotherapy techniques and drug therapies (1973-1988). Some narrative and summary biographical information about Dr. Goldin as well as a complete set of his reprints (1937-1976) make up the remaining significant portions of the papers.